E-LIB Suche - Ergebnisse für: Langley, Richard G. B.

1

25985 Efficacy of tildrakizumab 100 mg for PASI improvement..:

Lebwohl, Mark G. ; Langley, Richard G.B. ; Sinclair, Rodney...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB78 , 2021

Link: https://doi.org/10.1016/..

2

Ixekizumab treatment and the impact on SF-36: results from ..:

Langley, Richard G. B. ; Reich, Kristian ; Strand, Vibeke...
Quality of Life Research. 29 (2020) 2 - p. 369-380 , 2020

Link: https://www.jstor.org/st..

3

Ixekizumab treatment and the impact on SF-36: results from ..:

Langley, Richard G. B. ; Reich, Kristian ; Strand, Vibeke...
Quality of Life Research. 29 (2019) 2 - p. 369-380 , 2019

Link: https://doi.org/10.1007/..

4

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, i..:

Papp, Kim ; Reich, Kristian ; Leonardi, Craig L....
Journal of the American Academy of Dermatology. 73 (2015) 1 - p. 37-49 , 2015

Link: https://doi.org/10.1016/..

5

Sustained Efficacy and Safety of Pimecrolimus Cream 1% when..:

Langley, Richard G. B. ; Eichenfield, Lawrence F. ; Lucky, Anne W....
Pediatric Dermatology. 25 (2008) 3 - p. 301-307 , 2008

Link: https://doi.org/10.1111/..

6

Targeting the Interleukin-12/23 Cytokine Family in the Trea..:

Shear, Neil H. ; Prinz, Jörg ; Papp, Kim..
Journal of Cutaneous Medicine and Surgery. 12 (2008) 6_suppl - p. S1-S10 , 2008

Link: https://doi.org/10.2310/..

7

CLinical Experience Acquired with Raptiva® (CLEAR) trial in..:

Sterry, Wolfram ; Stingl, Georg ; Langley, Richard G.B....
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 4 (2006) 11 - p. 947-956 , 2006

Link: https://doi.org/10.1111/..

8

Mycosis Fungoides Presenting as Pigmented Purpuric Dermatit..:

Hanna, Shannon ; Walsh, Noreen ; D'Intino, Yolanda.
Pediatric Dermatology. 23 (2006) 4 - p. 350-354 , 2006

Link: https://doi.org/10.1111/..

9

In vivo confocal scanning laser microscopy of benign lentig..:

Langley, Richard G.B. ; Burton, Elizabeth ; Walsh, Noreen..
Journal of the American Academy of Dermatology. 55 (2006) 1 - p. 88-97 , 2006

Link: https://doi.org/10.1016/..

10

Safety, Efficacy, and Dosage of 1% Pimecrolimus Cream for t..:

L??bbe, Jann ; Friedlander, Sheila F ; Cribier, Bernard...
American Journal of Clinical Dermatology. 7 (2006) 2 - p. 121-131 , 2006

Link: https://doi.org/10.2165/..

11

CLEAR‐Studie (CLinical Experience Acquired with Raptiva®[mi..:

Sterry, Wolfram ; Stingl, Georg ; Langley, Richard G.B....
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 4 (2006) 11 - p. , 2006

Link: https://doi.org/10.1111/..

12

Prognostic Significance of Vascularity in Cutaneous Melanom..:

Humphrey, Shannon ; Walsh, Noreen M. ; Delaney, Laura..
Journal of Cutaneous Medicine and Surgery. 10 (2006) 3 - p. 122-127 , 2006

Link: https://doi.org/10.2310/..

13

Incidence of infection during efalizumab therapy for psoria..:

Langley, Richard G.B. ; Carey, Wayne P. ; Rafal, Elyse S....
Clinical Therapeutics. 27 (2005) 9 - p. 1317-1328 , 2005

Link: https://doi.org/10.1016/..

14

Erdheim-Chester Disease of the Breast: A Case Report and Re..:

Barnes, Penny J. ; Foyle, Annette ; Hache, Kelly A. Dakin...
The Breast Journal. 11 (2005) 6 - p. 462-467 , 2005

Link: https://doi.org/10.1111/..

15

Topical Calcineurin Inhibitors in the Treatment of Atopic D..:

Iskedjian, Michael ; Piwko, Charles ; Shear, Neil H..
American Journal of Clinical Dermatology. 5 (2004) 4 - p. 267-279 , 2004

Link: https://doi.org/10.2165/..